Lawrence M Pfeffer

Title: Innovations in Cancer Treatment by Lawrence M. Pfeffer

Introduction

Lawrence M. Pfeffer is a notable inventor based in Memphis, TN (US), recognized for his contributions to cancer research. He has developed innovative therapies aimed at treating therapy-resistant cancers, particularly glioblastoma. His work focuses on the development of bromodomain inhibitors that enhance the effectiveness of existing chemotherapeutic agents.

Latest Patents

Pfeffer holds a patent for "Bromodomain inhibitors to target therapy-resistant cancer." This patent describes novel inhibitors of the bromodomain of Brahma-related gene 1 (BRG1). The invention outlines methods for treating glioblastoma using these inhibitors in combination with chemotherapeutics, such as DNA alkylating agents. The inhibitors are designed to sensitize glioblastoma cells, including those that are chemoresistant, to agents like temozolomide and carmustine.

Career Highlights

Pfeffer is affiliated with the University of Tennessee Research Foundation, where he conducts his research. His work has significantly advanced the understanding of how to combat glioblastoma, a particularly aggressive form of brain cancer. His innovative approaches have the potential to improve treatment outcomes for patients facing this challenging disease.

Collaborations

Pfeffer has collaborated with esteemed colleagues, including Duane Douglas Miller and Yali He. These partnerships have fostered a collaborative environment that enhances the research and development of effective cancer therapies.

Conclusion

Lawrence M. Pfeffer's contributions to cancer treatment through his innovative research and patents highlight the importance of developing new therapeutic strategies. His work continues to pave the way for advancements in the fight against glioblastoma and other therapy-resistant cancers.